Follow The Filings

COO Cooper Companies Inc.

Health Care, filed as COOPER COS INC (COM), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

Bought by 2 managers in 2026 Q2, sold by 2

  • 5 Owners
  • Max 13.5%
  • $362M
  • 2 new 2 reduce 1 small

In 2026 Q2 Estuary Capital Management and Bill Nygren / Oakmark opened positions in Cooper Companies, while Torray Investment Partners and Ron Baron trimmed.

Who owns this now

Largest portfolio weights among holders, up to 13.5% (Jana Partners Management). Not free-float ownership.

  1. Jana Partners Management Add 13.5%
  2. Estuary Capital Management New 3.1%
  3. Torray Investment Partners Reduce 0.23%
  4. Bill Nygren / Oakmark New 0.07%
  5. Ron Baron Reduce 0.05%

Who owns COO

Sorted by value, long equity only, as of 2026 Q2.

History
Jana Partners Management 13.5% Small add +0.5% 3,582,480 $257M History
Bill Nygren / Oakmark, Harris Associates L P 0.07% New 0.07% 766,520 $55M History
Ron Baron, Bamco Inc. (Baron Capital) 0.05%, was 0.10% Reduce −5.9% 427,888 $31M History
Estuary Capital Management 3.1% New 3.1% 252,300 $18M History
Torray Investment Partners 0.23%, was 0.27% Reduce −8.4% 23,286 $1.7M History

5 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by COO's executives, directors and 10% owners in the last 12 months, from their Form 4s

All COO insider trades
  • $3.2M bought by 7 insiders
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. Lawrence Erik Kurzius Director
    Buy
    $549K 10,000 shares at $54.93 +47% to stake
    Traded Sep 16 Filed Sep 17
    ↗
  2. Paul A Keel Director
    Buy
    $250K 4,701 shares at $53.18 New stake
    Traded Sep 11 Filed Sep 15
    ↗
  3. Walter M Rosebrough Jr. Director
    Buy
    $542K 10,000 shares at $54.16 +100% to stake
    Traded Sep 11–14 Filed Sep 15
    ↗
  4. Lawrence Erik Kurzius Director
    Buy
    $539K 10,000 shares at $53.92 +90% to stake
    Traded Sep 14 Filed Sep 15
    ↗
  5. Cynthia L Lucchese Director
    Buy
    $150K 1,784 shares at $84.06 +23% to stake
    Traded Dec 22, 2025 Filed Dec 23, 2025
    ↗
  6. Maria Rivas Director
    Buy
    $82K 1,000 shares at $82.13 +9.9% to stake
    Traded Dec 18, 2025 Filed Dec 19, 2025
    ↗
  7. Lawrence Erik Kurzius Director
    Buy
    $165K 2,000 shares at $82.50 +35% to stake
    Traded Dec 17, 2025 Filed Dec 17, 2025
    ↗
  8. Holly R Sheffield President, CSI
    Buy
    $99K 1,230 shares at $80.75 +3.3% to stake
    Traded Dec 16, 2025 Filed Dec 16, 2025
    ↗
  9. Albert G White III CEO
    Buy
    $808K 10,000 shares at $80.80 +4.4% to stake
    Traded Dec 16, 2025 Filed Dec 16, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 22 option exercises, 13 share withholdings for taxes, and 1 gift.

Congress

3 members of Congress traded COO in the last three years: 4 buys and 1 sale. 1 member listed it in 2025 annual reports.

All Congress trades
  1. Alan Armstrong R-OK Buy $1K–$15K Mar 27 filed Jul 21
  2. Gilbert Ray Cisneros, Jr. D-CA-31 Buy $1K–$15K Jun 5 filed Jul 2
  3. Gilbert Ray Cisneros, Jr. D-CA-31 Buy $1K–$15K May 29 filed Jun 8
  4. Gilbert Ray Cisneros, Jr. D-CA-31 Buy $1K–$15K Dec 10, 2025 filed Jan 12
  5. Robert P. Bresnahan, Jr. R-PA-8 Sell $1K–$15K May 15, 2025 filed Jun 9, 2025

SEC filings

Recent issuer filings from EDGAR, 16 shown.

Filed Form Detail Links
8-K 5.02,7.01,9.01 Filing Doc
10-Q Filing Doc
8-K 2.02,8.01,9.01 Filing Doc
10-Q Filing Doc
8-K 2.02,8.01,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 5.02 Filing Doc
SCHEDULE 13G — Filing Doc
8-K 5.07 Filing Doc
SCHEDULE 13G/A — Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc
8-K 1.01,9.01 Filing Doc
8-K 1.01,5.02,7.01,9.01 Filing Doc

Source: SEC EDGAR submissions, updated about 13 hours ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $3.59B $3.9B $4.09B
Gross profit $2.36B $2.6B $2.68B
Gross margin * 65.6% 66.6% 65.5%
Net income $294.2M $392.3M $374.9M
Net margin * 8.2% 10.1% 9.2%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $1.7B $1.95B $2.11B
Total non-current assets * $9.95B $10.36B $10.29B
Total assets $11.66B $12.32B $12.39B
Total current liabilities $0.969B $1.02B $1.11B
Total non-current liabilities * $3.14B $3.21B $3.04B
Total equity $7.55B $8.08B $8.24B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $607.5M $709.3M $796.1M
Cash from investing -$449M -$764.6M -$372.9M
Cash from financing -$173.9M $39.2M -$425.9M
Net change in cash -$17.7M -$13.2M $2.9M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.